Mechanisms of cytokine-mediated inhibition of viral replication

Virology

Volumn 259, Issue 2, 1999, Pages 334-341

  Komatsu, Takashi ^a   Srivastava, Neil ^a   Revzin, Margarita ^a   Ireland, Derek D C ^a   Chesler, David ^a   Shoshkes Reiss, Carol ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

Acquired immunity; Innate immunity; Interleukin 12; Nitric oxide synthase; Viral infection

Indexed keywords

CYTOKINE; INTERLEUKIN 12; NITRIC OXIDE SYNTHASE;

ARTICLE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; RNA TRANSLATION; VESICULAR STOMATITIS VIRUS; VIRUS INHIBITION; VIRUS REPLICATION;

RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 0033526830     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9801     Document Type: Article

References (64)

1. Akarid K., Sinet M., Desforges B., Gougerot-Pocidalo M. A. Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J. Virol. 69:1995;7001-7005.
2. Barna M., Komatsu T., Reiss C. S. Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection. Virology. 223:1996;331-343.
3. Bi Z., Quandt P., Komatsu T., Barna M., Reiss C. S. IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system. J. Immunol. 155:1995;5684-5689.
4. Bi Z., Reiss C. S. Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69:1995;2208-2213.
5. Bredt D. S., Snyder S. H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Aca. Sci. USA. 86:1989;90300-90303.
6. Bredt D. S., Snyder S. H. Nitric oxide: a physiological messenger molecule. Annu. Rev. Biochem. 63:1994;175-195.
7. Chan S. H., Perussia B., Gupta J. W., Kobayashi M., Pospisil M., Young H. A., Wolf S., Young S., Clark S. C., Trinchieri G. Induction of interferon-γ production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:1991;869-879.
8. Chehimi A., Valiante N., D'Andrea A., Rengaraju M., Rosado Z., Kobayashi M., Perussia B., Wolf S. F., Starr S. E., Trinchieri G. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur. J. Immunol. 23:1993;1826-1830.
9. Ciechanover A., Schwartz A. L. The ubiquitin-mediated proteolytic pathway: mechanisms of recognition of the proteolytic substrate and involvement in the degradation of native cellular proteins. FASEB J. 8:1994;182-191.
10. Constantinescu C. S., Frei K., Malipiero U., Rostami A., Fontana A. Astrocytes and microglial produce IL-12. Ann. NY Acad. Sci. 795:1996;323-333.
11. Coutelier J. P., Broeck J. V., Wolf S. F. Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 69:1995;1955-1958.
12. Dawson T. M., Dawson V. L. Nitric oxide: Actions and pathological roles. The Neuroscientist. 1994;9-20.
13. Drapier J. C., Hibbs J. B. Jr. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J. Clin. Invest. 78:1986;790-797.
14. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
15. Galea E., Reis D. J., Feinstein D. C. Cloning and expression of inducible nitric oxide synthase from rat astrocytes. J. Neurosci. Res. 37:1994;406-414.
16. Garcia-Ruiz C., Morales A., Ballesta A., Rodes J., Kaplowitz N., Fernandez-Checa J. C. J. Clin. Invest. 139:1994;193-201.
17. Granger D. L., Lehninger A. L. Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells. J. Cell Biol. 95:1982;527-535.
18. Granger D. L., Taintor R. R., Cook J. L., Hibbs J. B. Jr. Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration. J. Clin. Invest. 65:1980;357-370.
19. Harris N., Mark R., Buller L., Karupiah G. Gamma interferon-induced nitric oxide-mediated inhibition of vaccinia virus replication. J. Virol. 69:1995;910-915.
20. Hibbs J. B. Jr., Taintor R. R., Vavin Z., Granger D. L., Drapier J.-C., Amber I. J., Lancaster J. R. ynthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: A molecular mechanism regulating cellular proliferation that targets intracellular iron. Higgs S. M. a. E. A. Nitric Oxide from L-arginine: A bioregulatory system. 1990;Elsevier Science Publishers, B.V. Amsterdam.
21. Hsieh C. S., Macatonia S. E., Tripp C. S., Wolf S. F., O'Garra A., Murphy K. M. Development of Th1 CD4 T cells through IL-12 produced by Listeria-induced macrophages. Science. 260:1993;547-549.
22. Huneycutt B. S., Bi Z., Aoki C. J., Reiss C. S. Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice. J. Virol. 67:1993;6698-6706.
23. Ireland D. D. C., Bang T., Komatsu T., Reiss C. S. Delayed administration of IL-12 is efficacious in promoting recovery from lethal viral encephalitis. Viral Immunol. 12:1999;35-40.
24. Johnson R. T., Burke D. S., Elwell M., Leake C. J., Nisalak A., Hoke C. H., Lorsomrudee W. Japanese encephalitis: Immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann. Neurol. 18:1985;567-573.
25. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., Le J., Koh S. I., Kimura Y., Green S. J., Mak T. W., Taniguchi T., Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 263:1994;1612-1615.
26. Karupiah G., Harris N. Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J. Exp. Med. 181:1995;2171-2179.
27. Karupiah G., Xie Q. W., Buller R. M. L., Nathan C., Duarte C., Macmicking J. D. Inhibition of viral replication by interferon-γ induced nitric oxide synthase. Science. 261:1993;1445-1448.
28. Kobayashi M., Fitz L., Ryan M., Hewick R. M., Clark S. C., Chan S., Loudon R., Sherman F., Perussia B., Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:1989;827-846.
29. Komatsu T., Bi Z., Reiss C. S. IFN-γ Induced Type I Nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunol. 68:1996;101-108.
30. Komatsu T., Ireland D., Reiss C. S. IL-12 and viral infections. Cytokine Growth Factor Rev. 9:1998;277-285.
31. Komatsu T., Ireland D., Zimmer S., Kang M., Reiss C. S. Neuronal expression of NOS-1 is required for host recovery from viral encephalitis. Virology. 258:1999a;389-395.
32. Komatsu T., Ireland D. D. C., Chung N., Doré A., Yoder M., Reiss C. S. Regulation of the blood brain barrier during VSV encephalitis: Roles of IL-12 and NOS. NO: Biol. Chem. 1999b.
33. Komatsu T., Reiss C. S. IFN-γ is not required in the IL-12 response to vesicular stomatitis virus infection of the olfactory bulb. J. Immunol. 159:1997;3444-3452.
34. Kwon N. S., Stuehr D. J., Nathan C. F. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med. 174:1991;761-767.
35. Lancaster J. R. Jr., Hibbs J. R. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc. Natl. Acad. Sci. USA. 87:1990;1223-1227.
36. Lawson N. D., Stillman E. A., Whitts M. A., Rose J. K. Recombinant vesicular stomatitis viruses from DNA. Proc. Natl. Acad. Sci. USA. 92:1995;4477-4481.
37. Lee S. C., Dickson D. W., Brosnan C. F., Casadevall A. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric-oxide mediated mechanism. J. Exp. Med. 180:1994;365-369.
38. Lepoivre M., Fieschi F., Coves J., Thelander L., Fontecave M. Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun. 179:1991;442-448.
39. Lin Y.-L., Huang Y.-L., Ma S.-H., Yeh C.-T., Chiou S.-Y., Chen L.-K., Liao C.-L. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of NO on RNA virus replication. J. Virol. 71:1997;5227-5235.
40. Manetti R., Parronchi P., Giudizi M. G., Piccinni M. P., Maggi E., Trinchieri G., Romagnani S. Natural killer stimulatory factor (interleukin 12) induces T helper type-1 (Th1)-specific immune responses and inhibits the development of IL-4-producing cells. J. Exp. Med. 177:1993;1199-1204.
41. Mannick J. B., Stamler J. S., Tang E., Finberg R. Nitric oxide inhibits human immunodeficiency virus replication. Stamer S. G. J.S., Moncada S.A., Hibbs J.B. Biology of Nitric Oxide. 1996;Portland Press, London.
42. Marletta M. A. Nitric oxide synthase: Aspects concerning structure and catalysis. Cell. 78:1994;927-930.
43. Meissner H. C., Schlievert P. M., Leung D. Y. Immunol. Rev. 139:1994;109-123.
44. Merill J. E., Ignarro L. J., Sherman M. P., Melinek J., Lane T. E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
45. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
46. Nathan C., Xie Q. W. Nitric oxide synthase: Roles, tolls, and controls. Cell. 78:1994;915-918.
47. Orange J. S., Salazar-Mather T. P., Opal S. M., Spencer R. L., Miller A. H., McEwen B. S., Biron C. A. Mechanism of interleukin-12-mediated toxicities during experimental viral infections: Role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:1995;901-914.
48. Orange J. S., Wolf S. F., Biron C. A. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1994;1253-1264.
49. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
50. Pellat C., Henry Y., Drapier J.-C. IFN-γ-activated macrophages: Detection by electron paramagnetic resonance of complexes between L-arginine-derived nitric oxide and non-heme iron proteins. Biochem. Biophys. Res. Commun. 166:1990;119-125.
51. Peterson J. D., Herzenberg L. A., Vasquez K., Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc. Natl. Acad. Sci. USA. 95:1998;3071-3076.
52. Reiss C. S., Komatsu T. Minireview: Does nitric oxide play a critical roll in viral infections? J. Virol. 72:1998;4547-4551.
53. Schmidt H. H. H. W., Walter U. NO at work. Cell. 78:1994;919-925.
54. Schoenhaut D. S., Chua A. O., Wolitzky A. G., Guinn P. M., Dwyer C. M., McComas W., Familletti P. C., Gately M. K., Gubler U. Cloning and expression of murine IL-12. J. Immunol. 148:1992;3433-3440.
55. Seguin M. C., Klotz F. W., Schneider I., Weir J. P., Goodbary M., Slayter M., Raney J. J., Aniagolu J. U., Green S. J. Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes involvement of interferon gamma and CD8+ T Cells. J. Exp. Med. 180:1994;353-358.
56. Stalder A. K., Pagenstecher A., Yu N. C., Kincaid C., Chiang C. S., Hobbs M. V., Bloom F. E., Campbell I. L. Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. J. Immunol. 159:1997;1344-1351.
57. Stamler J. S. Redox signaling: nitrosylation and related target interaction of nitric oxide. Cell. 78:1994;931-936.
58. Stamler J. S., Singel D. J., Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 258:1992;1898-1902.
59. Stenger S., Thuring H., Rollinghoff M., Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania Major. J. Exp. Med. 180:1994;783-793.
60. Wagner R. R., Rose J. K. Rhabdoviridae. Fields B. N., Knipes D. M., Howley P. M. Fundamental Virology. 1996;561-575 Lippenscott -Raven Publishers, Philadelphia.
61. Wolf S. F., Sieburth D., Sypek J. Interleukin-12: A key modulator of immune functions. Stem Cell. 12:1994;154-168.
62. Wolf S. F., Temple P. A., Kobayashi M., Young D., Dicig M., Lowe L., Dizialo R., Fritz L., Ferenz C., Hewick R. M., Kelleher K., Herrmann S. H., Clark S. H., Azzoni L., Chan S. H., Trincheiri G., Perussia B. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biological effects on T and natural killer cells. J. Exp. Med. 146:1991;3074-3081.
63. Xie, J, Roddy, P, Rife, T. K, Murad, F, and, Young, A. P. 1995, Two closely linked but separable promoters for human neuronal nitric oxide synthase gene transcription, Proc. Natl. Acad. Sci. USA, 92, 1242.
64. Zielasek J., Tausch M., Toyka K. V., Hartung H. P. Production of nitrite by neonatal rat microglial cells/brain macrophages. Cell. Immunol. 141:1992;111-120.